Webinar Pre-Test: Fertility, Contraception, and Pregnancy in Women with Inflammatory Bowel Disease (IBD), Part 1/2

Pre-Test

Please take a minute to complete this pre-session survey both to gauge your existing knowledge of the subject matter in advance of the webinar (necessary to award of CME/CE credits) and also to help ARHP assess the impact of its educational programs. Completing this survey will provide ARHP with an invaluable tool for understanding how health professionals use educational offerings and how ARHP activities might be improved to serve you better.

Question Title

* 1. Today's date (MM/DD/YYYY):

Date

Question Title

* 2. Your primary professional category (choose the one best response):

Health Professional Educator

Nurse Midwife

Nurse Practitioner

Pharmacist

Physician

Physician Assistant

Registered Nurse

Resident

Student

Other (please specify)

Question Title

* 3. Do you interact with patients?

Yes

Question Title

* 4. How did you hear about this ARHP educational activity? (Please check all that apply.)

From an email from ARHP

From the ARHP website

From a colleague or friend

From social media (Facebook, Twitter, LinkedIn)

Other (please specify)

Question Title

* 5. In patients with IBD, how might hormone therapy such as estrogen-based OCPs and levonorgestrel IUDs affect cyclical symptoms?

A. Hormone therapy has been shown to improve cyclical symptoms

B. Hormone therapy has been shown to worsen cyclical symptoms

C. Hormone therapy has not been shown to have any effect on cyclical symptoms

D. Estrogen-based OCPs have been shown to worsen cyclical symptoms, while levonorgestrel IUDs have been shown to improve cyclical symptoms

Question Title

* 6. Which of the following contraceptive methods is NOT a level 1 recommendation according to the US Medical Eligibility Criteria (MEC) guidelines?

A. Copper IUD

B. Levonorgestrel IUD

C. Implant

D. Combined pill, patch, ring

Question Title

* 7. When is the optimal time for patients with IBD to conceive?

A. 1-2 months into remission

B. 3-6 months into remission

C. 1-2 weeks into remission

D. 3-6 weeks into remission

Question Title

* 8. Which of the following is NOT recommended for patients who conceive with active IBD?

A. Patient education counseling on fertility, pregnancy, and lactation

B. Discontinue treatment to mitigate harm to the pregnancy, because most IBD drugs are not safe during pregnancy

C. Continue treatment to maintain remission, because most IBD drugs are safe to use during pregnancy

D. Planned C-sections are not necessary unless there are vulval or perianal symptoms

Question Title

* 9. As a result of participating in this activity, I hope to be better able to:

Thank you for completing this pre-session questionnaire.